Results 271 to 280 of about 3,441,901 (408)
Noncoding RNAs in Host–Microbiota Interaction
The intricate interplay between gut microbiota and the host exerts a profound impact on host biological processes and disease development. This review highlights the pivotal role of noncoding RNAs (ncRNAs) in this interaction. Host ncRNAs regulate gene expression and microbiota composition, whereas microbial small RNAs (sRNAs) modulate host gene ...
Ziyi Zhao+7 more
wiley +1 more source
Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery
American Journal of Hematology, EarlyView.
Sebastian Vuong+3 more
wiley +1 more source
Objective Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT1) and endothelin‐1 type A receptor (ETAR), leading to autoantibody‐mediated ...
Wieke M. van Oostveen+8 more
wiley +1 more source
Thrombopoietin levels in Quebec platelet disorder-Implications for the mechanism of thrombocytopenia. [PDF]
Hayward CPM, Tasneem S, Rivard GE.
europepmc +1 more source
Inherited and Acquired Disorders of Platelet Function [PDF]
Kerstin Jurk, Beate E. Kehrel
openalex +1 more source
Thrombocytopenia and Anemia After Cardiac Surgery
American Journal of Hematology, EarlyView.
Myriam Beshai+2 more
wiley +1 more source
Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and Vasculitis
Systemic vasculitis describes a collection of rare diseases each caused by inflammation of blood vessel walls that can cause severe systemic complications [[3, 4]](#ref‐0003). The pattern of vascular inflammation and resultant damage is frequently variable and may be mimicked, or directly triggered, by infection or malignancy.
Michelle L. Robinette, Hetty E. Carraway
wiley +1 more source
Objective To evaluate the applicability of the 2016 EULAR/ACR/PRINTO macrophage activation syndrome (MAS) classification criteria in patients with Still's disease (sJIA‐SD) treated with IL‐1‐targeted therapy and to assess the incidence of MAS in this context.
Remco G.A. Erkens+14 more
wiley +1 more source